SK hynix Inc. (000660.KS) vs Merck & Co., Inc. (MRK)

See how SK hynix Inc. and Merck & Co., Inc. differ across market data and performance, so you can decide which asset best fits your strategy.

$1,080.72
KSE
SK hynix Inc. is a South Korean semiconductor company and one of the world’s largest producers of memory chips. Its core products include DRAM and NAND flash memory used in data centers, personal computers, smartphones, servers, and artificial intelligence infrastructure. The company plays an important role in the global supply chain for advanced computing, with demand tied closely to cloud services, enterprise hardware, mobile devices, and high-performance AI systems.
View Full Page
$152.23
NYSE
Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.
View Full Page

Key Metrics Comparison

SK hynix Inc.000660.KS
Market Cap
$767.151B
Price
$1,080.72
24h Change
-9.75%
24h Volume
$0
Employees
N/A
Shares Outstanding
N/A
Merck & Co., Inc.MRK
Market Cap
$375.578B
Price
$152.23
24h Change
+12.62%
24h Volume
$29.34M
Employees
73,000
Shares Outstanding
2,469,879,206

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
000660.KS
67.1%
MRK
32.9%

Volume Share

Share of combined 24h volume

Volume Share
000660.KS
1.0%
MRK
100.0%

24h Performance

Price change over last 24 hours

24h Performance
000660.KS
-9.75%
MRK
12.62%
Price Comparison
SK hynix Inc.
Merck & Co., Inc.